Shares of Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $75.00 and last traded at $75.00, with a volume of 4 shares traded. The stock had previously closed at $75.00.
Pharma Mar Price Performance
The business has a 50 day moving average price of $68.88 and a 200-day moving average price of $47.33. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.01 and a current ratio of 2.55.
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
- Five stocks we like better than Pharma Mar
- Most active stocks: Dollar volume vs share volume
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Investing In Preferred Stock vs. Common Stock
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Low PE Growth Stocks: Unlocking Investment Opportunities
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
